Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-20

Clinical Trial Update: Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of brodalumab in psoriatic arthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • brodalumab (brodalumab)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2020-08-20